Page 3 - Five Prime Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This Week In Securities Litigation (Week of August 28, 2023)

Summer is heading for its traditional close at Labor Day as many have either returned to school or are finalizing their plans. The Commission…

United statesNew jerseyHong kongJohn desalvoDaniel vt catenacciFutures commission of hong kongBiopharma corpEcom products group corporationSquare bizStem biotechJersey department of correctionsExchange act sectionsA fair fundMatter of black spade acquisition coExchange act sectionTherapeutics inc

SEC gov | Daniel V T Catenacci

SEC gov | Daniel V T Catenacci
sec.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sec.gov Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoMadiham zuberiDaniel vt catenacciDavid zhouJohns rymasMoniquec winklerExchange commissionDetection centerSecurities exchangeTherapeutics incUs district courtSan francisco regional officeLitigation releaseFinal judgment againstNorthern district

AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data.

United kingdomSaudi arabiaPuerto ricoUnited statesMacau generalSouth koreaUnited arab emiratesHong kongGreat britainCelllung cancerandDavidm reeseJessica akopyanJustin claeysMost sustainable companiesTherapeutics incEuropean union

AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING

AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Hong kongSaudi arabiaUnited statesUnited kingdomSouth koreaPuerto ricoUnited arab emiratesMacau generalGreat britainDavidm reeseJustin claeysCelllung cancerandJessica akopyanDrug administrationExchange commissionEuropean union

Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society Annual Meeting and the European Society for Medical Oncology in the fall Enrollment for HPN328 .

Julie eastlandHaibo wangRoberth uhlInternational myeloma societyHarpoon therapeutics incBusiness development at amgenAbbvie restated researchHarpoon development option agreementExchange commissionEuropean society for medical oncologyBusiness developmentBusiness development at hummingbird bioscienceAnnual meetingEuropean societyMedical oncologyHarpoon therapeutics